What we found on the web about Genentech
Genentech - Wikipedia, the free encyclopedia
Genentech Inc., a portmanteau of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and ...
MedImmune, Inc. v. Genentech, Inc. - Wikipedia, the free encyclopedia
MedImmune, Inc. v. Genentech, Inc., 549 U.S. 118 was a decision by the Supreme Court of the United States involving patent law. It arose from a lawsuit filed by MedImmune which ...
Genentech - Company Overview - Hoover's
"The few, the proud, the profitable" could be Genentech's motto. One of the world's most successful biotechs (in an industry full of... Full Company Description for Genentech
DNA: Summary for GENENTECH INC- Yahoo! Finance
Get detailed information on GENENTECH INC (DNA) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
Genentech Foundation
Genentech Foundation Description ... Prospective grantees should familiarize themselves with our eligibility criteria, restrictions and submission deadlines.
Genentech - SourceWatch
Genentech, Inc. is financially one of the world's most successful biotechnology corporations. The company has three drugs that are billion-dollar sellers: Rituxan, for non-Hodgkin ...
Genentech
For 30 years, Genentech has been at the forefront of the biotechnology industry, using human genetic information to discover, develop, manufacture and commercialize ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Genentech

Genentech Inc., a portmanteau of Genetic Engineering Technology, Inc., is a leading biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer. "Genentech was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. After a fateful meeting in 1976, the two decided to start the first biotechnology company, Genentech." It is considered to have founded the biotechnology industry. One of its founders, Boyer, is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of interest from one source, to be ligated into a similarly cut plasmid vector. While Cohen returned to the laboratory in academia, Swanson contacted Boyer to found the company. Boyer worked with Arthur Riggs and Keiichi Itakura from the Beckman Research Institute, and the group became the first to successfully express a human gene in bacteria when they produced the hormone somatostatin in 1977. David Goeddel and Dennis Kleid were then added to the group, and contributed to its success with synthetic human insulin in 1978.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Genentech
Arthur Levinson Leaves Google’s Board of Directors
Mashable
Without giving any specific reasons for the departure, Google announced that Arthur Levinson has resigned from the company’s Board of Directors. Levinson is a former Chief Executive Officer and current chairman of the Board of Directors of ...
Genentech and Biogen Idec Receive a Complete Response from the FDA for ...
Forbes
BusinessWire - Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the compani...
Google Loses Another Board Member
redOrbit
Google announced on Monday that Arthur Levinson had removed himself from their board after a rise in the examination of his membership as a head of both Google and Apple Inc.The retirement of Levinson, the former director of Genentech and a...
Arthur Levinson departs Google board amid FTC probe
Engadget
We kind of doubt the departure of Genentech's former chief executive from Google's board of directors will close all of this out in the FTC's eyes, but if you were curious about the impact of said probe , here's your answer. Just two months...
Genentech and Biogen Idec Receive a Complete Response from the FDA for ...
Stockhouse
Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), and Biogen Idec (Nasdaq: BIIB) announced today that the U.S. Food and Drug Administration (FDA) issued a complete response on the companies' application...
Levinson quits Google board amid govt scrutiny
CIOL
The resignation by Levinson, the former chief executive of Genentech and a Google board member since 2004, comes about two months after Google CEO Eric Schmidt quit the board of the maker of Mac computers and iPhones.
Genentech Submits Supplemental Applications to FDA for Avastin ...
Forbes
BusinessWire - Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administrati...
This Week in Science
DAILY KOS
Presented for your approval, two very different sides of the same coin, a company caught in the age old human struggle between right and wrong: Genetech the good ; Genentech the not so good . Quick, the suited figure by the sign post up ahe...
Genentech Pharma Partnering Guide 2008
TMCnet
The Genentech Partnering Guide 2008 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies. Using this report, dealmakers will effectively and efficiently determine the suit...
Genentech Submits Supplemental Applications to FDA for Avastin ...
Phramalive.com
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 17, 2009 - Genentech, Inc., a wholly-owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the company submitted two supplemental Biologics License Applications ...
Google-Apple board ties severed; collaboration next to go?
Ars Technica
Apple and Google severed their last official ties Monday morning, as Arthur Levinson has resigned from Google's Board of Directors. The former Genentech CEO had been sitting on the company's board since 2004 and Apple's board since 2000, bu...
Genentech's biosimilar lobbying blitz blasted by NYT
FierceBiotech
In a move designed to demonstrate bipartisan support for provisions in a healthcare bill that includes 12 years of market exclusivity for biologics, Genentech was able to persuade some 22 Republicans and 20 Democrats in Congress to insert v...